Related Experiment Videos
Potassium supplementation for the management of primary hypertension in adults
Insights
Potassium supplementation did not significantly lower blood pressure in individuals with elevated levels. More high-quality, longer-term studies are needed to confirm these findings on blood pressure and health outcomes.
Area of Science:
- Cardiovascular Health
- Nutritional Science
- Clinical Trials
Background:
- Inconsistent epidemiological data exists regarding potassium's effect on blood pressure.
- Elevated blood pressure (hypertension) is a significant global health concern.
Purpose of the Study:
- To assess the impact of potassium supplementation on blood pressure and health outcomes in individuals with elevated blood pressure.
- To synthesize evidence from randomized controlled trials (RCTs) on potassium's hypertensive effects.
Main Methods:
- Systematic literature search across multiple databases (Cochrane Library, MEDLINE, EMBASE, etc.).
- Inclusion of parallel or crossover RCTs with >=8 weeks follow-up in adults (>=18 years) with elevated SBP (>=140 mmHg) or DBP (>=85 mmHg).
- Random effects meta-analyses and sensitivity analyses were performed on extracted data.
Main Results:
- Six RCTs (n=483) met the criteria; meta-analysis of five trials (n=425) showed non-significant reductions in SBP (MD: -11.2 mmHg) and DBP (MD: -5.0 mmHg).
- Substantial heterogeneity was observed and not explained by dose, quality, or baseline blood pressure.
- Sensitivity analyses, including exclusion of a high-baseline BP trial and focus on high-quality trials, also yielded non-significant blood pressure reductions.
Conclusions:
- This review found no statistically significant effect of potassium supplementation on blood pressure.
- The evidence remains inconclusive due to small sample sizes, short follow-up, and unexplained heterogeneity.
- Further high-quality, longer-duration RCTs are necessary to definitively determine potassium's role in blood pressure management and health outcomes.
Background:
Epidemiological evidence on the effects of potassium on blood pressure is inconsistent.
Objectives:
To evaluate the effects of potassium supplementation on health outcomes and blood pressure in people with elevated blood pressure.
Search Strategy:
We searched the Cochrane Library, MEDLINE, EMBASE, Science Citation Index, ISI Proceedings, ClinicalTrials.gov, Current Controlled Trials, CAB abstracts, and reference lists of systematic reviews, meta-analyses and randomised controlled trials (RCTs) included in the review.
Selection Criteria:
Inclusion criteria were: 1) RCTs of a parallel or crossover design comparing oral potassium supplements with placebo, no treatment, or usual care; 2) treatment and follow-up >=8 weeks; 3) participants over 18 years, with raised systolic blood pressure (SBP) >=140 mmHg or diastolic blood pressure (DBP) >=85 mmHg); 4) SBP and DBP reported at end of follow-up. We excluded trials where: participants were pregnant; received antihypertensive medication which changed during the study; or potassium supplementation was combined with other interventions.
Data Collection And Analysis:
Two reviewers independently extracted data and assessed trial quality. Disagreements were resolved by discussion or a third reviewer. Random effects meta-analyses and sensitivity analyses were conducted.
Main Results:
Six RCT's (n=483), with eight to 16 weeks follow-up, met our inclusion criteria. Meta-analysis of five trials (n=425) with adequate data indicated that potassium supplementation compared to control resulted in a large but statistically non-significant reductions in SBP (mean difference: -11.2, 95% CI: -25.2 to 2.7) and DBP (mean difference: -5.0, 95% CI: -12.5 to 2.4). The substantial heterogeneity between trials was not explained by potassium dose, quality of trials or baseline blood pressure. Excluding one trial in an African population with very high baseline blood pressure resulted in smaller overall reductions in blood pressure (SBP mean difference: -3.9, 95% CI: -8.6 to 0.8; DBP mean difference: -1.5, 95% CI: -6.2 to 3.1). Further sensitivity analysis restricted to two high quality trials (n=138) also found non-significant reductions in blood pressure (SBP mean difference: -7.1, 95% CI: -19.9 to 5.7; DBP mean difference: -5.5, 95% CI: -14.5 to 3.5).
Authors' Conclusions:
This systematic review found no statistically significant effect of potassium supplementation on blood pressure. Because of the small number of participants in the two high quality trials, the short duration of follow-up, and the unexplained heterogeneity between trials, the evidence about the effect of potassium supplementation on blood pressure is not conclusive. Further high quality RCTs of longer duration are required to clarify whether potassium supplementation can reduce blood pressure and improve health outcomes.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Hypertension I: Introduction
Hypertension V: Nursing Management